FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2122156976> ?p ?o ?g. }

• W2122156976 endingPage "30251" @default.
• W2122156976 startingPage "30244" @default.
• W2122156976 abstract "Dual oxidase 2 (Duox2) is a cell surface glycoprotein that probably provides thyroperoxidase with the H2O2 required to catalyze thyroid hormone synthesis. No functional H2O2-generating system has yet been obtained after transfecting Duox2 into non-thyroid cell lines, because it is retained in the endoplasmic reticulum (ER). We investigated the level of maturation of various Duox2 truncated proteins in an attempt to identify the region of Duox2 responsible for its remaining in the ER. Duox2-Q686X mutant, corresponding to the N-terminal ectodomain including the first putative transmembrane domain, was expressed in different cell lines. Carbohydrate content analysis revealed that complex type-specific Golgi apparatus (GA) oligosaccharides were present on pig Duox2-Q686X, whereas human truncated Duox2 carried only high mannose-type sugar chains characteristic of the ER. Further characterization using surface biotinylation and flow cytometry assays indicated that pig Duox2-Q686X was present at the plasma membrane, whereas human Duox2-Q686X remained inside the cell. The replacement of the last 90 residues of the human Duox2-Q686X with the pig equivalent region allowed the chimerical peptide to reach the Golgi apparatus. Pig mutants containing the complete first intracellular loop with or without the second transmembrane domain accumulated in the ER. These findings show that 1) the human Duox2-Q686X region encompassing residues 596–685 prevents mutant exportation from the ER and 2) there is a pig Duox2 retention domain in the first intracellular loop. In addition, missense mutations of four cysteines (Cys-351, -370, -568, or -582) completely inhibited the emergence of pig Duox2-Q686X from the ER compartment, indicating their importance in Duox2 maturation. Dual oxidase 2 (Duox2) is a cell surface glycoprotein that probably provides thyroperoxidase with the H2O2 required to catalyze thyroid hormone synthesis. No functional H2O2-generating system has yet been obtained after transfecting Duox2 into non-thyroid cell lines, because it is retained in the endoplasmic reticulum (ER). We investigated the level of maturation of various Duox2 truncated proteins in an attempt to identify the region of Duox2 responsible for its remaining in the ER. Duox2-Q686X mutant, corresponding to the N-terminal ectodomain including the first putative transmembrane domain, was expressed in different cell lines. Carbohydrate content analysis revealed that complex type-specific Golgi apparatus (GA) oligosaccharides were present on pig Duox2-Q686X, whereas human truncated Duox2 carried only high mannose-type sugar chains characteristic of the ER. Further characterization using surface biotinylation and flow cytometry assays indicated that pig Duox2-Q686X was present at the plasma membrane, whereas human Duox2-Q686X remained inside the cell. The replacement of the last 90 residues of the human Duox2-Q686X with the pig equivalent region allowed the chimerical peptide to reach the Golgi apparatus. Pig mutants containing the complete first intracellular loop with or without the second transmembrane domain accumulated in the ER. These findings show that 1) the human Duox2-Q686X region encompassing residues 596–685 prevents mutant exportation from the ER and 2) there is a pig Duox2 retention domain in the first intracellular loop. In addition, missense mutations of four cysteines (Cys-351, -370, -568, or -582) completely inhibited the emergence of pig Duox2-Q686X from the ER compartment, indicating their importance in Duox2 maturation. During thyroid hormone synthesis, thyroperoxidase (TPO) 1The abbreviations used are: TPO, thyroperoxidase; Duox, dual oxidase; Hek293, human embryonic kidney cell 293; CHO, Chinese hamster ovary; CHAPS, 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic acid; ER, endoplasmic reticulum; GA, Golgi apparatus; TMD, transmembrane domain; GFP, green fluorescent protein; PBS, phosphate-buffered saline; PBS-CM, PBS supplemented with 1 mm CaCl2 and 1 mm MgCl2.1The abbreviations used are: TPO, thyroperoxidase; Duox, dual oxidase; Hek293, human embryonic kidney cell 293; CHO, Chinese hamster ovary; CHAPS, 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic acid; ER, endoplasmic reticulum; GA, Golgi apparatus; TMD, transmembrane domain; GFP, green fluorescent protein; PBS, phosphate-buffered saline; PBS-CM, PBS supplemented with 1 mm CaCl2 and 1 mm MgCl2. catalyzes the iodination of tyrosyl residues on thyroglobulin and couples hormonogenic pairs of iodotyrosine molecules to form iodothyronines (1Taurog A. Braverman L.E. Utiger R.D. Werner and Ingbar's The Thyroid. 8th Ed. Lippincott-Raven Publishers, Philadelphia2000: 61-85Google Scholar). This synthesis occurs on the outside of the apical plasma membrane of thyrocytes in the presence of hydrogen peroxide, which acts as an electron acceptor (2Ekholm R. Mol. Cell. Endocrinol. 1981; 24: 141-163Crossref PubMed Scopus (97) Google Scholar). The H2O2-generating system associated with TPO is a calcium-dependent NADPH:O2 oxidoreductase, which has a catalytic core containing a 1548-amino acid integral membrane flavoprotein encoded by the DUOX2 gene (3Dupuy C. Ohayon R. Valent A. Noel-Hudson M.S. Deme D. Virion A. J. Biol. Chem. 1999; 274: 37265-37269Abstract Full Text Full Text PDF PubMed Scopus (370) Google Scholar, 4Deme D. Doussiere J. De Sandro V. Dupuy C. Pommier J. Virion A. Biochem. J. 1994; 301: 75-81Crossref PubMed Scopus (38) Google Scholar, 5De Deken X. Wang D. Many M.C. Costagliola S. Libert F. Vassart G. Dumont J.E. Miot F. J. Biol. Chem. 2000; 275: 23227-23233Abstract Full Text Full Text PDF PubMed Scopus (489) Google Scholar). A biallele inactivating mutation on the DUOX2 gene was found in a patient with a total iodide organification defect; this confirmed the essential role of Duox2, probably as a supplier of H2O2 for TPO (6Moreno J.C. Bikker H. Kempers M.J.E. Van Trotsenburg P. Baas F. de Vijlder J.J.M. Vulsma T. Ris-Stalpers C. N. Engl. J. Med. 2002; 347: 95-102Crossref PubMed Scopus (381) Google Scholar). The DUOX1 gene, situated near DUOX2 on chromosome 15q15, encodes a homologous 1551-amino acid protein displaying 83% sequence similarity (5De Deken X. Wang D. Many M.C. Costagliola S. Libert F. Vassart G. Dumont J.E. Miot F. J. Biol. Chem. 2000; 275: 23227-23233Abstract Full Text Full Text PDF PubMed Scopus (489) Google Scholar). DUOX mRNAs are also detected in epithelial cells of some secretory glands and mucosal surfaces, where these enzymes could provide H2O2 for peroxidase-mediated antimicrobial defense processes (7Dupuy C. Pomerance M. Ohayon R. Noel-Hudson M.S. Deme D. Chaaraoui M. Francon J. Virion A. Biochem. Biophys. Res. Commun. 2000; 277: 287-292Crossref PubMed Scopus (58) Google Scholar, 8Geiszt M. Witta J. Baffi J. Lekstrom K. Leto T.L. FASEB J. 2003; 17: 1502-1504Crossref PubMed Scopus (407) Google Scholar). The Duox glycoprotein sequence can be divided into three parts, each extending over about one-third of the molecule (Fig. 1). The C-terminal region, comprising the last six TMDs of Duox, displays high sequence similarities with the other members of the NAD(P)H oxidase family (9Lambeth J.D. Cheng G. Arnold R.S. Edens W.A. Trends Biochem. Sci. 2000; 25: 459-461Abstract Full Text Full Text PDF PubMed Scopus (328) Google Scholar), indicating that it probably catalyzes the transfer of electrons across the membrane from NADPH to molecular oxygen. The large intracellular loop located in the middle part of Duox, between the first two TMDs, contains two potential calcium EF-hand binding motifs and is probably involved in the control by calcium of the conformation and activity of NADPH oxidase (10Leseney A.M. Deme D. Legue O. Ohayon R. Chanson P. Sales J.P. Carvalho D.P. Dupuy C. Virion A. Biochimie (Paris). 1999; 81: 373-380Crossref PubMed Scopus (55) Google Scholar, 11Gorin Y. Leseney A.M. Ohayon R. Dupuy C. Pommier J. Virion A. Deme D. Biochem. J. 1997; 321: 383-388Crossref PubMed Scopus (23) Google Scholar). The ∼600-residue-long extracellular N-terminal part of the protein is in part homologous to animal heme peroxidases and distinguishes the Duox family from other NAD(P)H oxidases. Edens et al. (12Edens W.A. Sharling L. Cheng G. Shapira R. Kinkade J.M. Lee T. Edens H.A. Tang X. Sullards C. Flaherty D.B. Benian G.M. Lambeth J.D. J. Cell Biol. 2001; 154: 879-891Crossref PubMed Scopus (312) Google Scholar) reported that the peroxidase-like domain of Duox1, which is expressed in bacteria, catalyzes protein cross-linking by forming dityrosine bonds in the bacterial lysate. However, the role of the homologous domain of Duox2 in thyroid hormone biosynthesis is still poorly understood, and its peroxidase activity apparently duplicates that of TPO. The sequence of porcine Duox2 includes six putative N-glycosylated sites located in the N-terminal ectodomain, whereas only five such sites have been identified in the human protein. Western blots of membrane proteins from human and pig thyrocytes displayed Duox2 as two bands corresponding to two differently N-glycosylated states of Duox2 with oligosaccharide motifs accounting for 15 and 25 kDa of their molecular mass, respectively (13Morand S. Chaaraoui M. Kaniewski J. Deme D. Ohayon R. Noel-Hudson M.S. Virion A. Dupuy C. Endocrinology. 2003; 144: 1241-1248Crossref PubMed Scopus (65) Google Scholar, 14De Deken X. Wang D. Dumont J.E. Miot F. Exp. Cell Res. 2002; 273: 187-196Crossref PubMed Scopus (155) Google Scholar). Only the more highly glycosylated form was resistant to endoglycosidase H treatment, indicating that it passes through the GA and also suggesting that it constitutes the mature form of the NAD(P)H oxidase at the plasma membrane (14De Deken X. Wang D. Dumont J.E. Miot F. Exp. Cell Res. 2002; 273: 187-196Crossref PubMed Scopus (155) Google Scholar). No reconstitution of a functional H2O2-generating system based on Duox1 or Duox2 proteins has yet been achieved. Human Duox expressed in CHO and COS cells remains exclusively intracellular, with no post-ER maturation (14De Deken X. Wang D. Dumont J.E. Miot F. Exp. Cell Res. 2002; 273: 187-196Crossref PubMed Scopus (155) Google Scholar). Some unidentified components are probably required to target the Duox proteins toward the GA or to retain Duox in the ER (6Moreno J.C. Bikker H. Kempers M.J.E. Van Trotsenburg P. Baas F. de Vijlder J.J.M. Vulsma T. Ris-Stalpers C. N. Engl. J. Med. 2002; 347: 95-102Crossref PubMed Scopus (381) Google Scholar, 14De Deken X. Wang D. Dumont J.E. Miot F. Exp. Cell Res. 2002; 273: 187-196Crossref PubMed Scopus (155) Google Scholar). To explore this latter possibility, we expressed C-terminal-deleted mutants of human and porcine Duox2 in Hek293, CHO, and PCCL3 cells. The first mutants, termed human and pig Duox2-Q686X, respectively, included the peroxidase-like ectodomain and the first TMD (Figs. 1 and 2). This exactly matched the truncated protein probably expressed in the thyroid of a patient with the C2056T monoallelic mutation on the DUOX2 gene and exhibiting a partial iodide-organification defect phenotype (6Moreno J.C. Bikker H. Kempers M.J.E. Van Trotsenburg P. Baas F. de Vijlder J.J.M. Vulsma T. Ris-Stalpers C. N. Engl. J. Med. 2002; 347: 95-102Crossref PubMed Scopus (381) Google Scholar). The other mutants used were the longer porcine Duox2-H1038X and Duox2-V1075X proteins, truncated before and after the second TMD, respectively (Fig. 1). In this study, we investigated the maturation of these mutants in terms of their N-glycosylation states and subcellular localization. The role of the cysteine residues located in the ectodomain was also investigated in the intracellular trafficking using site-directed mutagenesis. Generation of Duox2 Constructs—Human and pig DUOX2 open reading frame cDNAs were amplified by RT-PCR using 1 μg of human or pig thyroid mRNA with primers designed according to the GenBank™ data base (NM_014080 and AF547267 for human and pig DUOX2 cDNA, respectively). Human and pig DUOX2 products (4.6 kb) were cloned into pcDNA3.1D/TOPO vectors (Invitrogen) and sequenced. Human and pig Duox2-Q686X were amplified by PCR using these plasmids. The sense PCR primers used for human and pig Duox2 constructs included the ATG start codon followed by 27 nucleotides. The antisense PCR primers for human and pig Duox2-Q686X were 5′-CTAGACCACACGGAGCACAGTGAGATGCCT-3′, and 5′-CTAGATGGTAC GGAGCACTGAGAGATGCCT-3′, respectively, where the bold letters correspond to the stop codon. Human and pig Duox2-Q686X products (2.0 kb) were also cloned into pcDNA3.1D/TOPO vectors (Invitrogen) and sequenced. To generate stable cell lines using the Flp-In™ system (Invitrogen), human and pig Duox2-Q686X inserts were subcloned into pcDNA5/FRT, using KpnI/NotI. Human and pig Duox2-(1–685) fused in-frame with green fluorescent protein (GFP) were produced by PCR using human and pig pcDNA3.1D/Duox2 plasmids as templates. The antisense PCR primers for human and pig Duox2·GFP were 5′-CGACCACACGGAGCACAGTGAGATG-3′ and 5′-CGATGGTAC GGAGCACTGAGAGATG-3′, respectively. The PCR products were cloned into pcDNA3.1/CT·GFP-TOPO vector (Invitrogen) and sequenced. Pig Duox2-H1038X and pig Duox2-V1075X fragments were amplified by PCR using pig pcDNA3.1D/Duox2 plasmid with the antisense primer 5′-TCACCGCCGAT AATTCTCCACAAAGCGCTTGTA-3′ and 5′-TCAAAAGGGGTCTCTGCAATGCCCGAGGG-3′, respectively. The fragments were cloned into pcDNA3.1D/TOPO vector and sequenced. The chimerical construct coding the first 595 amino acids of the human Duox2 followed by amino acids 596–685 of the pig Duox2 was obtained by overlapping PCR using human and pig pcDNA3.1D/Duox2 plasmids as templates (15Klug J. Wolf M. Beato M. Nucleic Acids Res. 1991; 19: 2793Crossref PubMed Scopus (15) Google Scholar). The sense and antisense primers used to amplify the human Duox2-(1–595) sequence were 5′-CCCAAGCTTATGCTCCGTGCAAGACCAGAGGCACTGATG-3′ (primer 1, containing a HindIII restriction site and the start codon) and 5′-TACGATGGTGATGCCAAAACCGGGGCTGCTGCCTTCAAAGAAGTCAAG-3′ (primer 2), respectively. The sense and antisense primers used to amplify the pig Duox2-(596–685) sequence were 5′-CCGCTCGAGTCAGATGGTACGGAGCACTGAGAGATGCCT-3′ (primer 3, containing a XhoI restriction site and the stop codon) and 5′-CTTGACTTCTTTGAAGGCAGCAGCCCCGGTTTTGGCATCACCATCGTA-3′ (primer 4), respectively. The PCR products (1.8 and 0.2 kb, respectively) were purified, mixed together, and submitted to a 15-cycle PCR without adding primers and then to a 30-cycle PCR with primers 1 and 3. The PCR fusion product (2.0 kb) was then digested by HindIII/XhoI, cloned into pcDNA5/FRT plasmid, and sequenced. Cysteines in pig Duox2-Q686X were replaced by glycines by site-directed mutagenesis using the QuikChange kit (Stratagene). Primers containing the desired mutation and the PCR conditions were selected according to the manufacturer's guidelines. Cell Cultures, Transfection, and Preparation of the Particulate Fraction—Rat thyroid cells (PCCL3), developed as described previously (16Fusco A. Berlingieri M.T. Di Fiore P.P. Portella G. Grieco M. Vecchio G. Mol. Cell. Biol. 1987; 7: 3365-3370Crossref PubMed Scopus (246) Google Scholar), were a generous gift from Dr. R. Di Lauro (Stazione Zoologica Anton Dohrn, Napoli, Italy). They were cultured in Coon's modified Ham's F12 medium (VWR) supplemented with 10% fetal calf serum, 10 microunits of bovine thyrotropin (Sigma), 1 μg/ml insulin, 5 μg/ml transferrin, and 10 nm hydrocortisone. Flp-In™ CHO and Flp-In™ Hek293 cell lines (Invitrogen) were grown at 37 °C in Ham's F-12 medium (Invitrogen) and in Dulbecco's modified Eagle's medium (Invitrogen), respectively, supplemented with 10% fetal calf serum, antibiotics, and Zeocin™. When they reached 50–60% confluence, the cells were transiently transfected by using the FuGENE (Roche Applied Sciences) transfection reagent. After 24 h, 20 μm hemin and 10 mm sodium butyrate were added to the medium; the PCCL3 cells were also supplemented with 10 μm forskolin. After 48 h, cells were washed with PBS and scraped into the same solution supplemented with a mixture of protease inhibitors (5 μg/ml aprotinin, 5 μg/ml leupeptin, 1 μg/ml pepstatin, 157 μg/ml benzamidine). After centrifuging at 200 × g for 10 min at 4 °C, the cell pellet was homogenized using a motor-driven Teflon pestle homogenizer in 2 ml of 50 mm sodium phosphate buffer containing 0.25 m sucrose, 0.1 mm dithiothreitol, 1 mm EGTA (pH 7.2) and the mixture of protease inhibitors. After centrifuging at 3,000 × g for 30 min, the pellet was resuspended in 0.5 ml of 50 mm sodium phosphate buffer (pH 7.2) containing 0.25 m sucrose, 1 mm MgCl2, and the mixture of protease inhibitors. Deglycosylation Experiments—Deglycosylation was performed as follows: 100 μg of particulate fraction was treated either in 50 mm phosphate buffer (pH 7.4) containing the antiprotease mixture, 2.5 mm EDTA, 0.1% SDS, before adding 50 units/ml N-glycosidase F (Roche Applied Sciences) or in 100 mm sodium citrate buffer, (pH 5.5) containing the antiprotease mixture, 2.5 mm EDTA, 0.1% SDS, before adding 1 unit/ml Endoglycosidase H (Roche Applied Sciences). After a 1-h incubation, an additional 50 units/ml N-glycosidase F or 1 unit/ml endoglycosidase H was added, and the incubation was continued for a further 1 h. Controls were performed under the same conditions except that deglycosylation enzymes were omitted. The reaction was stopped by adding concentrated Laemmli sample buffer before performing electrophoresis. Western Blot Analysis—SDS-PAGE and immunoblot analyses were performed as described previously (17Caillou B. Dupuy C. Lacroix L. Nocera M. Talbot M. Ohayon R. Deme D. Bidart J.M. Schlumberger M. Virion A. J. Clin. Endocrinol. Metab. 2001; 86: 3351-3358PubMed Google Scholar). The Duox2 protein was detected using the polyclonal IgG antipeptide raised against the 14-amino acid peptide encompassing the Leu-410-Thr-423 portion of human and porcine Duox2. This antipeptide does not detect rat Duox2 protein. Cell Surface Biotinylation—Flp-In™ Hek293 and Flp-In™ CHO cells were stably transfected with pig and human pcDNA5/FRT-Duox2-Q686X, respectively, and clones were selected in a hygromycin-B-supplemented culture medium. Resistant clones were screened for positive Duox2-Q686X expression by Western blot analysis. Cell monolayers grown in 35-mm Petri dishes were washed twice with ice-cold PBS (pH 8.0) supplemented with 1 mm CaCl2 and 1 mm MgCl2 (PBS-CM) before sulfo-NHS-biotin (Pierce) was added at the concentration of 0.5 mg/ml in PBS-CM for 10 min on ice. Control cells were treated without sulfo-NHS-biotin. The reagent was removed, and the same operation was repeated once. The medium was then removed, and the remaining reactive sulfo-NHS-biotin was blocked by adding 50 mm NH4Cl in PBS-CM. The cells were then washed with PBS-CM before adding 600 μl of solubilization buffer containing 50 mm Tris-HCl (pH 7.4), 10 mm CHAPS, and the antiprotease mixture. Cells were incubated for 30 min on ice while being gently shaken and then centrifuged for 30 min at 200,000 × g. The supernatant was incubated for 2 h with 200 μl of avidin-agarose (Sigma). The biotinylated surface Duox2-Q686X and the intracellular Duox2-Q686X were separated by centrifuging (1 min, 9,000 × g). The beads were washed seven times at 4 °C with extraction buffer and twice with PBS-CM, resuspended in 100 μl of Laemmli sample buffer, and boiled for 5 min. 50 μl of the supernatant corresponding to the cell surface fraction and 5 μl of the supernatant corresponding to the intracellular fraction were analyzed by SDS-PAGE and immunoblot. Fluorescence-activated Cell Sorter Analysis—Flp-In™ Hek293 and Flp-In™ CHO cells stably expressing pig and human Duox2-Q686X, respectively, were washed with PBS and detached from the plates using PBS containing 5 mm EDTA and 5 mm EGTA for 10 min at 37 °C before being transferred into polypropylene tubes (107 cells/tube). Cells were washed three times with PBS and centrifuged at 200 × g for 5 min at room temperature; the supernatant was then removed by inversion. Cells were then incubated at 4 °C with 2 ml of complete culture medium. After 1 h, they were washed with PBS and centrifuged at 400 × g for 3 min. They were then incubated for 45 min at 4 °C with 400 μl of complete culture medium containing 8 μl of antipeptide. Cells were washed three times with PBS and centrifuged as above. They were then incubated for 30 min at 4 °C in the dark with fluorescein-conjugated F(ab′)2 goat anti-rabbit IgG (H+L) (Caltag) in the same buffer. Cells were washed three times as above and resuspended in 400 μl of PBS. Controls were done using wild type Flp-In™ Hek293 and Flp-In™ CHO cells. The fluorescence was assayed by fluorescence-activated cell sorter using an Epics Elite cytometer (Coulter). Confocal Microscopy—Flp-In™ Hek293 and Flp In™ CHO cells transiently transfected with human and pig pcDNA3.1Duox2-(1–685)-CT·GFP were grown on a coverslip (Superior) and fixed with 4% paraformaldehyde at room temperature during 10 min. Cells were then washed twice for 5 min with PBS at room temperature and mounted in Mowiol. Cells were viewed with a ZEISS-LSM 510 laser scanning confocal microscope using a ×63/1.4 NA oil immersion objective lens. GFP was excited at 488 nm, and fluorescence emission was detected using a 505-nm-long pass filter. The pinhole was set at one Airy unit. Expression and Deglycosylation Studies of Human and Pig Duox2-Q686X in Hek293, CHO, and PCCL3 Cell Lines—Two non-thyroid cell lines (Hek293 and CHO) and a rat thyroid cell line (PCCL3) were transiently transfected with expression vectors encoding the human or pig Duox2-Q686X mutant. During the transfection period, the medium was supplemented with hemin because heme incorporation might affect flavoprotein maturation processing as previously reported for TPO and Nox2 (18Fayadat L. Niccoli-Sire P. Lanet J. Franc J.L. J. Biol. Chem. 1999; 274: 10533-10538Abstract Full Text Full Text PDF PubMed Scopus (77) Google Scholar, 19Yu L. Zhen L. Dinauer M.C. J. Biol. Chem. 1997; 272: 27288-27294Abstract Full Text Full Text PDF PubMed Scopus (126) Google Scholar, 20DeLeo F.R. Burritt J.B. Yu L. Jesaitis A.J. Dinauer M.C. Nauseef W.M. J. Biol. Chem. 2000; 275: 13986-13993Abstract Full Text Full Text PDF PubMed Scopus (136) Google Scholar), and PCCL3 were stimulated with forskolin to express the differentiation markers. Membrane proteins were then analyzed by Western blot, and human truncated Duox2 was visualized as a single immunoreactive band with an apparent molecular mass of 85 kDa (Fig. 3, lanes H). Surprisingly, the polyclonal antipeptide immunodetected the pig Duox2-Q686X protein as a doublet (Fig. 3, lanes P). One band had the same apparent molecular mass of 85-kDa as the human mutant, but a second protein was revealed as a broad band of ∼100 kDa. Each band could correspond to a specific glycosylation state of the protein, as previously observed for the full-length Duox2 (13Morand S. Chaaraoui M. Kaniewski J. Deme D. Ohayon R. Noel-Hudson M.S. Virion A. Dupuy C. Endocrinology. 2003; 144: 1241-1248Crossref PubMed Scopus (65) Google Scholar). Indeed, the calculated molecular mass of Duox2-Q686X mutants is only 70 kDa, but they contain all the putative N-glycosylation sites of human and porcine Duox2, numbering five and six sites, respectively. Deglycosylation experiments were therefore performed to check this assumption. The particulate fractions were digested with N-glycosidase F (NGaseF) or endoglycosidase H (EndoH) and analyzed by Western blot. The treatment with NGaseF or EndoH of Hek293, CHO, and PCCL3 particulate fractions expressing human Duox2-Q686X shifted the 85-kDa form to a 70-kDa protein with the predicted molecular mass of the non-glycosylated protein (Fig. 4, A–C). The NGaseF treatment of protein extracts from Hek293, CHO, and PCCL3 cells expressing the pig Duox2-Q686X mutant converted the doublet into a single band, reducing the apparent molecular mass of the 85 and 100-kDa forms by 15 and 25 kDa, respectively (Fig. 4, D–F, lanes F). However, the 100-kDa form of pig Duox2-Q686X was not affected by digestion with EndoH, whereas the 85-kDa protein was still converted into the 70-kDa form (Fig. 4, C–E, lanes H). Taken together, these findings indicate that the glycosylation of pig truncated Duox2 protein passed through the GA, unlike the corresponding human protein, which exhibited only ER-specific oligosaccharide motifs.Fig. 4Analysis of the glycosylation states of human and pig Duox2-Q686X mutants. Flp-In™ Hek293 (A–D), Flp-In™ CHO (B–E), and PCCL3 (C–F) cells were transiently transfected for 48 h with human (A–C) or pig (D–F) pcDNA3.1D/Duox2-Q686X, and the particulate fractions of the cells were treated with or without (–) N-glycosidase F (F) or endoglycosidase H (H) as described under “Experimental Procedures.”View Large Image Figure ViewerDownload (PPT) Cell Surface Expression of Duox2-Q686X Mutants—The differences observed in the glycosylation states of the human and porcine mutants might reflect differing subcellular distributions of the proteins. In particular, the evidence for a GA-specific glycosylation of the pig protein suggested that it could be targeted to the plasma membrane. Cell surface biotinylation experiments, carried out with a non-permeable reagent, were performed on the Hek293 and CHO cell lines stably expressing pig and human Duox2-Q686X mutants, respectively. Sulfo-NHS-biotin treatment revealed that a fraction of the porcine mutant 100-kDa form was present at the cell surface, whereas the partially glycosylated protein could not be biotinylated (Fig. 5A). Fig. 5B shows the human Duox2-Q686X 85-kDa protein was not expressed at the plasma membrane. The presence of the Duox2-Q686X protein at the plasma membrane was also measured by flow cytometry analysis. Fig. 6A demonstrates the binding of the antipeptide to the plasma membrane of nonpermeabilized cells expressing pig Duox2-Q686X, whereas no such fluorescence intensity shift was observed with human Duox2-Q686X (Fig. 6B). Duox2-(1–685)-CT·GFP fusion protein expressed for 48 h in both cell lines also provided evidence of a species-dependent subcellular distribution of each protein. Again, the porcine fusion protein expressed in Hek293 and CHO cells was detected in the Western blot experiment as a doublet, whereas the human tagged protein appeared as a single immunoreactive band (data not shown). When analyzed by confocal microscopy, the porcine fusion protein was found at the cell plasma membrane (Fig. 7, A and B), but we also observed intracellular fluorescence on other cellular sections. The human GFP-tagged mutant was visualized only as intracellular spots (Fig. 7, C and D).Fig. 6Flow cytometric analysis of the cell surface expression of human and pig Duox2-Q686X mutants. A, histogram of fluorescence intensity (arbitrary units) showing the binding of the antipeptide to Flp-In™ Hek293 expressing the pig Duox2-Q686X mutant (open histogram) or without the Duox2 mutant (dark gray histogram). B, histogram of fluorescence intensity showing the binding of the antipeptide to Flp-In™ CHO expressing the human Duox2-Q686X mutant (white histogram) or without the Duox2 mutant (dark gray histogram).View Large Image Figure ViewerDownload (PPT)Fig. 7Subcellular localization of human and pig Duox2-(1–685)-CT·GFP chimeras. Fluorescence images of pig Duox2-(1–685)-CT·GFP chimera transiently expressed in Flp-In™ Hek293 (A, a) and Flp-In™ CHO (B, a) cell lines with differential interference contrast images of the corresponding fields (A, b and B, b). Fluorescence images of human Duox2-(1–685)-CT·GFP chimera transiently expressed in Flp-In™ Hek293 (C, a) and in Flp-In™ CHO (D, a) cell lines with differential interference contrast images of the corresponding fields (C, b and D, b). Each fluorescence image corresponds to the median section. The bar represents 5 μm.View Large Image Figure ViewerDownload (PPT) Expression and Deglycosylation Studies of the Human-Pig Chimerical Duox2-Q686X Protein Expressed in the Hek293 Cell Line—Proteasome-dependent endocytosis and degradation pathway has been reported to be implicated in the turnover of receptors (21van Kerkhof P. Govers R. Alves dos Santos C.M. Strous G.J. J. Biol. Chem. 2000; 275: 1575-1580Abstract Full Text Full Text PDF PubMed Scopus (153) Google Scholar). Hek293 cells stably expressing the human Duox2-Q686X mutant were therefore treated for 24 h with a specific proteasome inhibitor, the MG132 compound, to test the involvement of the ubiquitin/proteasome system in the rapid degradation of the human mature Duox2 form. Western blot analysis revealed no novel band over the ER-specific 85-kDa form but rather an increased amount of the unglycosylated human Duox2-Q686X protein (data not shown) A chimerical gene was constructed by fusing in-frame the human DUOX2 cDNA sequence coding the N-terminal ectodomain with the pig DUOX2 cDNA sequence coding from the first TMD to amino acid 685 (Fig. 8A). This construct was transiently expressed in Hek293 cells for 48 h. Membrane proteins were then submitted to Western blot analysis. The antipeptide antibody revealed the chimerical peptide as a doublet: one band had the same apparent molecular mass of 85 kDa as the human Duox2-Q686X mutant, but a second protein with a higher molecular mass was visualized under 100 kDa (Fig. 8B). Deglycosylation experiments demonstrated that this latter form had passed through the GA because the N-linked oligosaccharides were not affected by the endoglycosidase H treatment (Fig. 8C). These findings indicate that the replacement of the last 90 amino acids of the human Duox2-Q686X mutant by" @default.
• W2122156976 created "2016-06-24" @default.
• W2122156976 creator A5030448314 @default.
• W2122156976 creator A5035216089 @default.
• W2122156976 creator A5038380278 @default.
• W2122156976 creator A5045773242 @default.
• W2122156976 creator A5055997013 @default.
• W2122156976 creator A5060333382 @default.
• W2122156976 creator A5064285393 @default.
• W2122156976 creator A5069537237 @default.
• W2122156976 creator A5083508086 @default.
• W2122156976 creator A5084294287 @default.
• W2122156976 creator A5090932110 @default.
• W2122156976 date "2004-07-01" @default.
• W2122156976 modified "2023-10-17" @default.
• W2122156976 title "Targeting of the Dual Oxidase 2 N-terminal Region to the Plasma Membrane" @default.
• W2122156976 cites W118495084 @default.
• W2122156976 cites W1502445277 @default.
• W2122156976 cites W1603573817 @default.
• W2122156976 cites W1850391171 @default.
• W2122156976 cites W1963859587 @default.
• W2122156976 cites W1973512632 @default.
• W2122156976 cites W2000087274 @default.
• W2122156976 cites W2001591583 @default.
• W2122156976 cites W2014124696 @default.
• W2122156976 cites W2018488189 @default.
• W2122156976 cites W2022942610 @default.
• W2122156976 cites W2026346896 @default.
• W2122156976 cites W2028343348 @default.
• W2122156976 cites W2030463413 @default.
• W2122156976 cites W2041309279 @default.
• W2122156976 cites W2070706683 @default.
• W2122156976 cites W2079682797 @default.
• W2122156976 cites W2086832150 @default.
• W2122156976 cites W2126582177 @default.
• W2122156976 cites W2136261717 @default.
• W2122156976 cites W2144849411 @default.
• W2122156976 cites W2155083127 @default.
• W2122156976 cites W2158875146 @default.
• W2122156976 cites W2161997291 @default.
• W2122156976 cites W2327543792 @default.
• W2122156976 doi "https://doi.org/10.1074/jbc.m405406200" @default.
• W2122156976 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15150274" @default.
• W2122156976 hasPublicationYear "2004" @default.
• W2122156976 type Work @default.
• W2122156976 sameAs 2122156976 @default.
• W2122156976 citedByCount "34" @default.
• W2122156976 countsByYear W21221569762012 @default.
• W2122156976 countsByYear W21221569762013 @default.
• W2122156976 countsByYear W21221569762014 @default.
• W2122156976 countsByYear W21221569762015 @default.
• W2122156976 countsByYear W21221569762016 @default.
• W2122156976 countsByYear W21221569762018 @default.
• W2122156976 countsByYear W21221569762020 @default.
• W2122156976 countsByYear W21221569762021 @default.
• W2122156976 countsByYear W21221569762022 @default.
• W2122156976 countsByYear W21221569762023 @default.
• W2122156976 crossrefType "journal-article" @default.
• W2122156976 hasAuthorship W2122156976A5030448314 @default.
• W2122156976 hasAuthorship W2122156976A5035216089 @default.
• W2122156976 hasAuthorship W2122156976A5038380278 @default.
• W2122156976 hasAuthorship W2122156976A5045773242 @default.
• W2122156976 hasAuthorship W2122156976A5055997013 @default.
• W2122156976 hasAuthorship W2122156976A5060333382 @default.
• W2122156976 hasAuthorship W2122156976A5064285393 @default.
• W2122156976 hasAuthorship W2122156976A5069537237 @default.
• W2122156976 hasAuthorship W2122156976A5083508086 @default.
• W2122156976 hasAuthorship W2122156976A5084294287 @default.
• W2122156976 hasAuthorship W2122156976A5090932110 @default.
• W2122156976 hasBestOaLocation W21221569761 @default.
• W2122156976 hasConcept C138885662 @default.
• W2122156976 hasConcept C185592680 @default.
• W2122156976 hasConcept C2779664074 @default.
• W2122156976 hasConcept C2780980858 @default.
• W2122156976 hasConcept C41008148 @default.
• W2122156976 hasConcept C41625074 @default.
• W2122156976 hasConcept C41895202 @default.
• W2122156976 hasConcept C55493867 @default.
• W2122156976 hasConcept C76155785 @default.
• W2122156976 hasConcept C86803240 @default.
• W2122156976 hasConcept C95444343 @default.
• W2122156976 hasConceptScore W2122156976C138885662 @default.
• W2122156976 hasConceptScore W2122156976C185592680 @default.
• W2122156976 hasConceptScore W2122156976C2779664074 @default.
• W2122156976 hasConceptScore W2122156976C2780980858 @default.
• W2122156976 hasConceptScore W2122156976C41008148 @default.
• W2122156976 hasConceptScore W2122156976C41625074 @default.
• W2122156976 hasConceptScore W2122156976C41895202 @default.
• W2122156976 hasConceptScore W2122156976C55493867 @default.
• W2122156976 hasConceptScore W2122156976C76155785 @default.
• W2122156976 hasConceptScore W2122156976C86803240 @default.
• W2122156976 hasConceptScore W2122156976C95444343 @default.
• W2122156976 hasIssue "29" @default.
• W2122156976 hasLocation W21221569761 @default.
• W2122156976 hasOpenAccess W2122156976 @default.
• W2122156976 hasPrimaryLocation W21221569761 @default.
• W2122156976 hasRelatedWork W2044322474 @default.
• W2122156976 hasRelatedWork W2152234042 @default.

• next